ABSTRACT
Congenital toxoplasmosis is a parasitic disease that occurs due vertical transmission of the protozoan Toxoplasma gondii (T. gondii) during pregnancy. The parasite crosses the placental barrier and reaches the developing brain, infecting progenitor, glial, neuronal and vascular cell types. Although the role of Radial glia (RG) neural stem cells in the development of the brain vasculature has been recently investigated, the impact of T. gondii infection in these events is not yet understood. Herein, we studied the role of T. gondii infection on RG cell function and its interaction with endothelial cells. By infecting isolated RG cultures with T. gondii tachyzoites, we observed a cytotoxic effect with reduced numbers of RG populations together with decrease neuronal and oligodendrocyte progenitor populations. Conditioned medium (CM) from RG control cultures increased ZO-1 protein levels and organization on endothelial bEnd.3 cells membranes, which was impaired by CM from infected RG, accompanied by decreased trans-endothelial electrical resistance (TEER). ELISA assays revealed reduced levels of anti-inflammatory cytokine TGF-ß1 in CM from T. gondii-infected RG cells. Treatment with recombinant TGF-ß1 concomitantly with CM from infected RG cultures led to restoration of ZO-1 staining in bEnd.3 cells. Congenital infection in Swiss Webster mice led to abnormalities in the cortical microvasculature in comparison to uninfected embryos. Our results suggest that infection of RG cells by T. gondii negatively modulates cytokine secretion, which might contribute to endothelial loss of barrier properties, thus leading to impairment of neurovascular interaction establishment.
Subject(s)
Cell Differentiation , Cerebral Cortex/blood supply , Endothelial Cells/parasitology , Ependymoglial Cells/parasitology , Microvessels/parasitology , Neurovascular Coupling , Toxoplasma/pathogenicity , Toxoplasmosis, Cerebral/parasitology , Toxoplasmosis, Congenital/parasitology , Animals , Cell Line , Disease Models, Animal , Electric Impedance , Endothelial Cells/metabolism , Endothelial Cells/pathology , Ependymoglial Cells/metabolism , Ependymoglial Cells/pathology , Mice, Inbred C57BL , Microvessels/metabolism , Microvessels/pathology , Tight Junctions/metabolism , Tight Junctions/parasitology , Tight Junctions/pathology , Toxoplasmosis, Cerebral/metabolism , Toxoplasmosis, Cerebral/pathology , Toxoplasmosis, Congenital/metabolism , Toxoplasmosis, Congenital/pathology , Transforming Growth Factor beta1/metabolism , Zonula Occludens-1 Protein/metabolismABSTRACT
Toxoplasma gondii is the main infectious cause of human posterior retinochoroiditis, the most frequent clinical manifestation of congenital toxoplasmosis. This investigation was performed after neonatal screening to identify biomarkers of immunity associated with immunopathological features of the disease by flow cytometry. The study included infected infants without NRL and with retinochoroidal lesions (ARL, ACRL, and CRL) as well as noninfected individuals (NI). Our data demonstrated that leukocytosis, with increased monocytes and lymphocytes, was a relevant hematological biomarker of ARL. Immunophenotypic analysis also revealed expansion of CD14(+)CD16(+)HLA-DR(high) monocytes and CD56(dim) cytotoxic NK-cells in ARL. Moreover, augmented TCRγ δ (+) and CD8(+) T-cell counts were apparently good biomarkers of morbidity. Biomarker network analysis revealed that complex and intricated networks underscored the negative correlation of monocytes with NK- and B-cells in NRL. The remarkable lack of connections involving B-cells and a relevant shift of NK-cell connections from B-cells toward T-cells observed in ARL were outstanding. A tightly connected biomarker network was observed in CRL, with relevant connections of NK- and CD8(+) T-cells with a broad range of cell subsets. Our findings add novel elements to the current knowledge on the innate and adaptive immune responses in congenital toxoplasmosis.
Subject(s)
Adaptive Immunity/physiology , Biomarkers/metabolism , Immunity, Innate/physiology , Toxoplasmosis, Congenital/immunology , Toxoplasmosis, Congenital/metabolism , Female , Humans , Infant , Infant, Newborn , Lymphocytes/metabolism , Male , Monocytes/metabolism , Prospective StudiesABSTRACT
Toxoplasma gondii is one of the few pathogens that can cross the placenta. Frequency and severity of transmission vary with gestational age. While the control of acquired toxoplasmosis is already well explored, the control of materno-foetal transmission of the parasite remains almost unknown. This is partly due to the lack of an animal model to study this process. This review summarises the studies which have been undertaken and shows that the mouse is a valuable model despite obvious differences to the human case. The paramount role of the cellular immune response has been shown by several experiments. However, IFN-gamma has a dual role in this process. While its beneficial effects in the control of toxoplasmosis are well known, it also seems to have transmission-enhancing effects and can also directly harm the developing foetus. The ultimate goal of these studies is to develop a vaccine which protects both mother and foetus. Therefore, it is useful to study the mechanisms of natural resistance against transmission during a secondary infection. In this setting, the process is more complicated, involving both cellular and also humoral components of the immune system. In summary, even if the whole process is far from being elucidated, important insights have been gained so far which will help us to undertake rational vaccine research.
Subject(s)
Interferon-gamma/metabolism , Toxoplasmosis, Congenital/metabolism , Toxoplasmosis, Congenital/physiopathology , Female , Humans , Interferon-gamma/immunology , Pregnancy , Toxoplasmosis, Congenital/immunologyABSTRACT
A prominent neuropathological change observed in a murine model of congenital toxoplasmosis is cerebral cortical hypoplasia. In the early embryonic life of toxoplasmosis mice, the number of apoptotic cell observed in cerebral cortex is increased, indicating that increased number of apoptotic cells might relate to the pathogenetic mechanism of the cortical hypoplasia. Immunohistochemical expression of apoptosis-related factors, Bcl-2 and Bax has been studied in fetal murine brains infected with toxoplasma and in controls. Paraffin sections of the fetal brains on embryonic day (ED) 10, 12, 14, 16 and 18 were applied for the immunostains of Bcl-2 and Bax. Totally, 47 experimental animals (ED10: n=8, ED12: n=6, ED14: n=12, ED16: n=6, ED18: n=15) and 48 control animals (ED10: n=6, ED12: n=8, ED14: n=9, ED16: n=9, ED18: n=16) were examined. Bcl-2 positive cells were detected on ED10, whereas Bax positive cells appeared on ED14. No difference of Bcl-2 and Bax expression between toxoplasmosis and control groups was detected, suggesting that there is no clear relation between Bax-induced apoptosis and cortical dysplasia in congenital toxoplasmosis.
Subject(s)
Apoptosis/physiology , Cerebral Cortex/abnormalities , Nervous System Malformations/parasitology , Proto-Oncogene Proteins/metabolism , Toxoplasmosis, Cerebral/metabolism , Toxoplasmosis, Congenital/metabolism , Animals , Body Patterning/physiology , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Female , Fetus , Mice , Mice, Inbred C57BL , Nervous System Malformations/pathology , Nervous System Malformations/physiopathology , Neurons/metabolism , Neurons/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Toxoplasma/pathogenicity , Toxoplasma/physiology , Toxoplasmosis, Animal/metabolism , Toxoplasmosis, Animal/pathology , Toxoplasmosis, Animal/physiopathology , Toxoplasmosis, Cerebral/pathology , Toxoplasmosis, Cerebral/physiopathology , Toxoplasmosis, Congenital/pathology , Toxoplasmosis, Congenital/physiopathology , bcl-2-Associated X ProteinABSTRACT
The prenatal diagnosis of congenital toxoplasmosis is mainly based on biological tests performed on fetal blood and amniotic fluid. We studied the performance of neonatal diagnosis procedures and the results of fetal blood and amniotic fluid analysis. Of 127 women who contracted toxoplasmosis and underwent prenatal diagnosis, the postnatal serological follow-up was long enough to definitively diagnose congenital toxoplasmosis in 19 cases and to exclude it in 27 cases. Prenatal diagnosis allowed the detection of 94.7 per cent (18/19) of the infected fetuses. The sensitivities of tests in amniotic fluid and fetal blood were equivalent, 88.2 per cent (15/17) and 87.5 per cent (14/16), respectively. In fetal blood, biological techniques were positive in 12/16 cases and in 2/16 cases, serological tests were the only positive sign. The specificities of tests in amniotic fluid and fetal blood were respectively 100 per cent (23/23) and 86.3 per cent (19/22) (three false-positive serological results). These results, added to the lower morbidity of amniocentesis compared with cordocentesis, might lead to cordocentesis being abandoned in the prenatal diagnosis of congenital toxoplasmosis.